New Customers Get 10% Off – Use Code: LUX10

Secretagogue Stack

Tesamorelin / IPA

5.0 Reviews

CJC/Ipa Blend

A peptide blend combining Tesamorelin and Ipamorelin designed to stimulate growth hormone release through complementary pathways, studied for metabolic and hormonal regulation in research models. Premium Research Peptide.

Original price was: $84.99.Current price is: $76.49.

2 Day FAST Shipping

99%+ Purity Tests

Ships from USA

USA Lab Tested

We accept :

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

How Tesamorelin / IPA Works

The Science, Simplified

Dual-Pathway Growth Hormone Stimulation

This blend combines Tesamorelin, a stabilized GHRH analog, with Ipamorelin, a selective GHRP (Growth Hormone Releasing Peptide). They work on two different receptors in the pituitary gland simultaneously.
Key insight: Tesamorelin acts as the “gas pedal” by stimulating the GHRH receptor, while Ipamorelin acts as the “trigger” by mimicking ghrelin at the GHSR receptor. In research models, this dual action creates a synergistic effect, producing a much larger pulse of natural growth hormone than either peptide could achieve alone.
GE
Primary

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

COL
Strongest

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

Cu²⁺
Supportive

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

Targeted Visceral Fat Reduction

Tesamorelin is specifically FDA-approved in a clinical context (as Egrifta) for reducing excess abdominal fat in HIV patients with lipodystrophy.

Key insight: In metabolic research, this blend is highly valued for its ability to specifically target visceral adipose tissue (VAT)—the dangerous fat stored around internal organs—while sparing subcutaneous fat. The addition of Ipamorelin helps maintain lean muscle mass and improve recovery times during the fat-loss process.

Selective Secretagogue Profile

Unlike older GHRPs, Ipamorelin is "selective," meaning it does not significantly increase levels of cortisol, prolactin, or ACTH.

Key insight: This makes the TESA/IPA blend a preferred subject for studies focusing on long-term wellness and anti-aging. Researchers can observe the benefits of high growth hormone levels (improved skin elasticity, better sleep, and fat loss) without the stressful side effects associated with less selective peptides.

Wrinkle Reduction Comparison

Safety Profile from Research

What clinical studies report

This blend is considered a premium research subject due to its high selectivity and the established clinical history of Tesamorelin.

🧿 Common Digestive Issues

30%

Injection Site Redness

mild

10%

Increased Hunger

mild

5%

Joint Sensitivity

mild

Safety Advantage

Low Side-Effect Profile

  • No Cortisol Spikes: Because Ipamorelin is highly selective, it does not trigger the "stress hormone" response, making it safer for long-duration research.
  • Preserved Natural Rhythm: The blend stimulates natural pulses rather than a constant "bleed" (like CJC-DAC), which is generally viewed as more favorable for long-term endocrine health.
  • Insulin Sensitivity: While growth hormone can sometimes affect blood sugar, Tesamorelin has shown a neutral-to-positive effect on insulin sensitivity in several metabolic trials.

📊 Discontinuation Rates

🚫 Trial Exclusions

⚡ Regulatory Status

💡 Researcher Notes

Compound Information

Technical specifications for this 17mg blend

🔬 Molecular Profile

What Is TESA/IPA?

Full Blend Name

TESA / IPA (17mg Total)

Tesamorelin

11mg

Ipamorelin

6mg

Purity

≥99%

🧊 Storage Requirements

Stability Information

Lyophilized (powder)

Store at -20°C

for up to 2 years.

Reconstituted

Store at 2-8°C;

use within 14-21 days.

Light Sensitive

High

Both peptides are UV sensitive.

📋Research Status

Development History

Classification

GHRH / GHRP Synergistic Blend

Primary Goal

Visceral Fat Loss / Lean Mass Maintenance

US Status

Investigational Research Compound

WADA Status

Banned (S2. Hormone and Metabolic Modulators)

Frequently Asked Questions

Common questions about Tesamorelin / IPA

In research, it’s all about synergy. Tesamorelin is great at telling the body to make growth hormone, but Ipamorelin is great at telling the body to release it. By using the Tesamorelin / Ipamorelin Blend, you get a significantly more powerful result than doubling the dose of either one individually.
Yes. Tesamorelin is the only peptide specifically noted for its ability to reduce visceral fat (the hard fat behind the abdominal wall). When paired with Ipamorelin, it becomes an ideal subject for metabolic research focusing on body composition and the "middle-age" metabolic slowdown.
CJC-1295 (No DAC) is a general-purpose GHRH. Tesamorelin is a more "premium" and potent GHRH analog that is specifically tailored for fat metabolism. While CJC/IPA is a great all-rounder, TESA/IPA is often considered the superior choice for fat-loss-centric protocols.
Growth hormone secretagogues can occasionally impact glucose metabolism. However, Tesamorelin was specifically designed to minimize this impact, making it one of the more "metabolically friendly" options for researchers studying subjects with insulin sensitivity concerns.
No. While Tesamorelin itself is FDA-approved for specific medical conditions (Egrifta), this specific 11mg/6mg blend is an investigational research compound. It is not intended for human use and is sold strictly for laboratory settings.

Sources & References

Peer-reviewed research

  • Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

My Account
Follow Us
Linkedin X-twitter Icon-instagram-1 Facebook-square